Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
Clinical trial NCT01796717 · UNKNOWN
Trial details
- NCT number
- NCT01796717
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2016-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.